NCT07378813 Low Versus High Load Training and Parkinson's Disease
| NCT ID | NCT07378813 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Miami |
| Condition | Activity, Motor |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-01-30 |
| Primary Completion | 2027-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-01-30 with a primary completion date of 2027-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will compare the effects of high-load resistance training to low-load resistance training, on measures of muscle strength and power and tests of daily performance in older adults with Parkinson's disease.
Eligibility Criteria
Inclusion Criteria: * Parkinson's Disease Hoehn \& Yahr Stages 1-3 * Able to walk 50m unassisted * Able to understand and communicate in English * A Montreal Cognitive Assessment (MoCA) score above 18 Exclusion Criteria: * Uncontrolled cardiovascular or other neuromuscular disease that prevent participation in a training program * Any systemic inflammatory or autoimmune conditions such as rheumatoid arthritis, or other serious concomitant medical illness * Unresolved injury or surgery to the upper or lower limbs that prevents weight training.
Contact & Investigator
Joseph F. Signorile, PhD
PRINCIPAL INVESTIGATOR
University of Miami
Frequently Asked Questions
Who can join the NCT07378813 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 85 Years, studying Activity, Motor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07378813 currently recruiting?
Yes, NCT07378813 is actively recruiting participants. Contact the research team at exe453@miami.edu for enrollment information.
Where is the NCT07378813 trial being conducted?
This trial is being conducted at Coral Gables, United States.
Who is sponsoring the NCT07378813 clinical trial?
NCT07378813 is sponsored by University of Miami. The principal investigator is Joseph F. Signorile, PhD at University of Miami. The trial plans to enroll 60 participants.